Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Duff

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|November 1, 1987
Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humansH J Duff, L B Mitchell, D Manyari, et al.
The Journal of Biological Chemistry|June 5, 1991
Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytesM Taouis, R S Sheldon, R J Hill, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channelsR S Sheldon, H J Duff, E Thakore, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1982
Antiarrhythmic activity of the O-demethyl metabolite of encainideD M Roden, H J Duff, D Altenbern, et al.
Journal of Cardiovascular Pharmacology|July 21, 1999
Prolonged sinus node recovery time in humans after the intracoronary administration of a nitric oxide synthase inhibitorD V Exner, D M Goodhart, T J Anderson, et al.
Molecular Pharmacology|January 29, 2000
Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sitesJ P Lees-Miller, Y Duan, G Q Teng, et al.
American Heart Journal|April 1, 1982
Selection of an antiarrhythmic drug for a sudden-death-prevention trialR L Woosley, D M Roden, H J Duff, et al.
Circulation Research|August 1, 1989
Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channelR S Sheldon, R J Hill, N J Cannon, et al.
Journal of Cardiovascular Pharmacology|July 1, 1984
The antiarrhythmic activity of meobentine sulfate in manH J Duff, J A Oates, D M Roden, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
Electropharmacologic synergism with mexiletine and quinidineH J Duff, F D Kolodgie, D M Roden, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|November 1, 1987
Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humansH J Duff, L B Mitchell, D Manyari, et al.
The Journal of Biological Chemistry|June 5, 1991
Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytesM Taouis, R S Sheldon, R J Hill, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channelsR S Sheldon, H J Duff, E Thakore, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1982
Antiarrhythmic activity of the O-demethyl metabolite of encainideD M Roden, H J Duff, D Altenbern, et al.
Journal of Cardiovascular Pharmacology|July 21, 1999
Prolonged sinus node recovery time in humans after the intracoronary administration of a nitric oxide synthase inhibitorD V Exner, D M Goodhart, T J Anderson, et al.
Molecular Pharmacology|January 29, 2000
Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sitesJ P Lees-Miller, Y Duan, G Q Teng, et al.
American Heart Journal|April 1, 1982
Selection of an antiarrhythmic drug for a sudden-death-prevention trialR L Woosley, D M Roden, H J Duff, et al.
Circulation Research|August 1, 1989
Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channelR S Sheldon, R J Hill, N J Cannon, et al.
Journal of Cardiovascular Pharmacology|July 1, 1984
The antiarrhythmic activity of meobentine sulfate in manH J Duff, J A Oates, D M Roden, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
Electropharmacologic synergism with mexiletine and quinidineH J Duff, F D Kolodgie, D M Roden, et al.
Pageof 13